Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiogenesis
Reports outline angiogenesis study results from K.N. Ganjoo et al
April 22nd, 2008
According to recent research published in the Journal of Cancer Research and Clinical Oncology, " The role of angiogenesis has been extensively evaluated in solid tumors and more recently in hematologic malignancies. Several surrogate markers of angiogenesis including tumor VEGF, VEGF receptors, and microvessel density have correlated with outcome in some lymphoma studies." "This is a single institution retrospective study evaluating the role of angiogenesis markers in the clinical outcome of patients with diffuse large B cell lymphoma (DLBCL). Patients and methods A total of 97 patients with DLBCL diagnosed and managed at Indiana University between 1993 and 2001...
Source: Cancer Weekly (2008-04-22)
|
